683 Capital Management LLC Makes New $868,000 Investment in LifeVantage Co. (NASDAQ:LFVN)

683 Capital Management LLC purchased a new stake in LifeVantage Co. (NASDAQ:LFVN - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 49,500 shares of the company's stock, valued at approximately $868,000. 683 Capital Management LLC owned approximately 0.39% of LifeVantage at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of LFVN. LPL Financial LLC lifted its stake in LifeVantage by 301.0% in the 4th quarter. LPL Financial LLC now owns 211,039 shares of the company's stock valued at $3,700,000 after acquiring an additional 158,405 shares in the last quarter. EAM Investors LLC bought a new stake in shares of LifeVantage in the fourth quarter worth $1,056,000. Susquehanna International Group LLP boosted its holdings in LifeVantage by 83.5% during the fourth quarter. Susquehanna International Group LLP now owns 128,082 shares of the company's stock worth $2,245,000 after purchasing an additional 58,279 shares during the last quarter. Jane Street Group LLC bought a new position in LifeVantage in the fourth quarter valued at $608,000. Finally, O Shaughnessy Asset Management LLC increased its stake in LifeVantage by 56.2% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company's stock valued at $1,640,000 after buying an additional 33,658 shares during the last quarter. 35.32% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Craig Hallum began coverage on LifeVantage in a report on Tuesday, January 14th. They issued a "buy" rating and a $35.00 price objective for the company.

LifeVantage Trading Down 5.3 %

NASDAQ LFVN opened at $11.71 on Friday. LifeVantage Co. has a 12 month low of $5.22 and a 12 month high of $27.38. The stock has a 50 day moving average of $14.84 and a 200-day moving average of $16.31. The company has a market cap of $146.97 million, a PE ratio of 20.91 and a beta of 0.75.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.08. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a $0.04 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.37%. LifeVantage's payout ratio is 28.57%.

Insider Buying and Selling

In other LifeVantage news, Director Raymond B. Greer sold 8,000 shares of LifeVantage stock in a transaction on Monday, February 10th. The shares were sold at an average price of $20.15, for a total transaction of $161,200.00. Following the completion of the transaction, the director now directly owns 99,288 shares of the company's stock, valued at $2,000,653.20. The trade was a 7.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 20.65% of the stock is owned by insiders.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Want to see what other hedge funds are holding LFVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeVantage Co. (NASDAQ:LFVN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.